Sökresultat

ILLUMINATE - Increasing lutetium production while leveraging metabolic imaging to enhance theranostics effectiveness, is a new international consortium of academic and industrial leaders, with the aim to demonstrate the unique value of recently developed Metabolic Magnetic Resonance Imaging (MeMRI) visualizing chemical processes in the body to significantly improve effective application of therano

https://www.lbic.lu.se/explore-our-infrastructure/national-7t-facility/illuminate-consortium - 2026-10-07

The following process shows what happens when using LBIC and it contains the following steps:Project PlanningUser FeesThe research board and its decisionSupport from LBIC staff for approved projectsScientific resultsOwnership and handling of dataYou can read more about each step on their page in the menu. Applying for scan timeOne question that might arise is how to apply for scan time. This can b

https://www.lbic.lu.se/explore-our-infrastructure/general-information/lbic-preclinical-user-policy/usage-process - 2026-10-07

Projects start with a meeting between the researcher and LBIC staff representing the platform requested. The main goal of this first meeting is to inform each other on the preclinical imaging possibilities available (LBIC) and to identify the scientific questions and needs of the project (researcher). Publications provided by the researcher will be used to establish the strategy of the project. In

https://www.lbic.lu.se/explore-our-infrastructure/general-information/lbic-preclinical-user-policy/usage-process/project-planning - 2026-10-07

The project costs are calculated taking external (outside LU) as well as internal grants for equipment and staff into consideration. LBIC as a core facility is dependent on external as well as internal funding. In order to keep our machine park well maintained and our research output at the cutting edge we must implement user fees. These fees are predominantly used for maintenance and service cont

https://www.lbic.lu.se/explore-our-infrastructure/general-information/lbic-preclinical-user-policy/usage-process/user-fees - 2026-10-07

All projects performed on LBIC´s preclinical imaging platforms are evaluated before acceptance with respect to possibility to perform the intended experiments successfully, given the available equipment at LBIC. This evaluation is performed by the LBIC preclinical research board (RB). Please note that in the application the intended experiments should be described in their biological or medical co

https://www.lbic.lu.se/explore-our-infrastructure/general-information/lbic-preclinical-user-policy/usage-process/research-board-and-its-decisions - 2026-10-07

LBIC has a limited staff (for staff researchers and other staff members, see homepage). LBIC staff will to the best of their ability help researchers with their projects, given the complexity of the equipment. At present, however, LBIC cannot within its budget provide full service from start to goal for research groups that have received approval for their project.As a general rule, LBIC staff wil

https://www.lbic.lu.se/explore-our-infrastructure/general-information/lbic-preclinical-user-policy/usage-process/support-lbic-staff-approved-projects - 2026-10-07

AcknowledgementsIt is the mission of LBIC to “establish and provide a major translational bio-imaging center at Lund university, combining knowledge in the fields of medical physics, preclinical and clinical medicine, chemistry, technology and applied mathematics in order to develop imaging methods for the advanced study of human morphology, cellular metabolism and physiological function in health

https://www.lbic.lu.se/explore-our-infrastructure/general-information/lbic-preclinical-user-policy/usage-process/scientific-results - 2026-10-07

Regarding ownership of raw data (spectra, animal and sample images etc.) the juridical situation has been discussed with the LU juridical department. One interpretation can be that LBIC possess ownership of such raw data, but the juridical situation is unclear.LBIC´s policy at present is:LBIC (LU) has the right to use raw data as described above, however it is recommended that prior to public use

https://www.lbic.lu.se/explore-our-infrastructure/general-information/lbic-preclinical-user-policy/usage-process/ownership-and-handling-data - 2026-10-07

The Preclinical In Vivo Imaging platform provides advanced non-invasive imaging technologies for preclinical research. The platform combines Positron Emission Tomography (PET), Single Photon Emission Computed Tomography (SPECT), X-ray Computed Tomography (µCT), Magnetic Resonance Imaging (MRI) and MRI-guided Focused Ultrasound (FUS), offering complementary methods for anatomical, functional, metab

https://www.lbic.lu.se/getting-started-lbic/preclinical-vivo-imaging - 2026-10-07

The following policy outlines the principles and procedures governing the use of LBIC's preclinical imaging equipment. It includes the following sections:(A) Project Planning(B) User Fees(C) How to apply for scan time(D) The research board and its decision(E) Support from LBIC staff for approved projects(F) Scientific results(G) Ownership and handling of dataIn accordance with a decision taken at

https://www.lbic.lu.se/lbic-preclinical-user-policy - 2026-10-07

ServiceFaculty of Medicine Academia IndustryInstrument time* (SEK/h)900 1300 4000 Staff time** (SEK/h)800 900 1950 Bench time (SEK/h)(Radiochemistry lab D11) 350 550 800 Radioactive waste disposal600 SEK per experiment/imaging dayResearch board fee1500 SEK*4 h minimum booking for our in vivo imaging equipment, billed hourly after that**All working hours for our staff; imaging support (added on the

https://www.lbic.lu.se/getting-started-lbic/preclinical-vivo-imaging/prices - 2026-10-07

Meet our scientists: Sharpness and depth that moves research forwardAn article about LBIC and Pia Sundgren.Read the article (in Swedish only at the moment, opens in new window)

https://www.lbic.lu.se/news-events - 2026-10-07

Back to TEM embedding

https://www.lbic.lu.se/tem-embedding-1 - 2026-10-07

Back to previous page

https://www.lbic.lu.se/tem-embedding-2 - 2026-10-07

Back to previous page

https://www.lbic.lu.se/tem-embedding-3 - 2026-10-07

Back to previous page

https://www.lbic.lu.se/tem-negative-staining - 2026-10-07

Preclinical and 7T publications 2018Mostajeran M, Wetterling F, Blixt FW, Edvinsson L, Ansar S. Acute mitogen-activated protein kinase 1/2 inhibition improves functional recovery and vascular changes after ischaemic stroke in rat-monitored by 9.4 T magnetic resonance imaging. Acta Physiol (Oxf). 2018 May; 223(1):e12985, doi: 10.1111/apha.12985Sanchez-Heredia JD, Avendal J, Bibic A, Lau BK. Radiati

https://www.lbic.lu.se/explore-our-infrastructure/national-7t-facility/publications-national-7t-facility/publications-2018 - 2026-10-07

To discuss your project or gain access to our facilities, please contact the relevant platform representative.Preclinical User PolicyThe following policy outlines the principles and procedures governing the use of LBIC's preclinical imaging equipment:LBIC Preclinical User PolicyAcknowledgementPublications containing data generated using equipment or services provided by the Lund University Bioimag

https://www.lbic.lu.se/getting-started-lbic/general-information - 2026-10-07

Dummy page

https://www.lbic.lu.se/dummy-page - 2026-10-07

Lund University Bioimaging Centre (LBIC) is Lund University’s central infrastructure for advanced bioimaging and translational imaging research within the Faculty of Medicine. Established in 2008, LBIC provides researchers with access to state-of-the-art imaging technologies and multidisciplinary expertise spanning biological scales from molecules and cells to whole organisms and humans.LBIC is cu

https://www.lbic.lu.se/about-lbic - 2026-10-07